{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:47:54Z","timestamp":1772462874878,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.tmaid.2014.04.011","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T13:32:47Z","timestamp":1399642367000},"page":"485-493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: A randomized, open-label, multi-center study"],"prefix":"10.1016","volume":"12","author":[{"given":"Martin","family":"Alberer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Burchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Jelinek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emil","family":"Reisinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Beran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seetha","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Forleo-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Gniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alemnew F.","family":"Dagnew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwani","family":"Kumar Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"47","key":"10.1016\/j.tmaid.2014.04.011_bib1","first-page":"521","article-title":"Meningococcal vaccines: WHO position paper, November 2011","volume":"86","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"issue":"16","key":"10.1016\/j.tmaid.2014.04.011_bib2","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMra0906357","article-title":"Advances in the development of vaccines against Neisseria meningitidis","volume":"362","author":"Tan","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.tmaid.2014.04.011_bib3","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","article-title":"Meningococcal disease: clinical presentation and sequelae","volume":"30","author":"Pace","year":"2012","journal-title":"Vaccine"},{"issue":"Suppl. 2","key":"10.1016\/j.tmaid.2014.04.011_bib4","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"issue":"RR-2","key":"10.1016\/j.tmaid.2014.04.011_bib5","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Cohn","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.tmaid.2014.04.011_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/erv.10.147","article-title":"Menveo\u00ae: a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y","volume":"10","author":"Cooper","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"18","key":"10.1016\/j.tmaid.2014.04.011_bib7","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.tmaid.2014.04.011_bib8","doi-asserted-by":"crossref","first-page":"B18","DOI":"10.1016\/j.vaccine.2012.01.062","article-title":"Meningococcal vaccine development\u2013from glycoconjugates against MenACWY to proteins against MenB\u2013potential for broad protection against meningococcal disease","volume":"30","author":"Dull","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.tmaid.2014.04.011_bib9","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4161\/hv.6.11.12849","article-title":"Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo\u00ae) or Menactra\u00ae among healthy adolescents","volume":"6","author":"Gill","year":"2010","journal-title":"Hum Vaccin"},{"issue":"1","key":"10.1016\/j.tmaid.2014.04.011_bib10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1086\/599117","article-title":"Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents","volume":"49","author":"Jackson","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2014.04.011_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/INF.0b013e31823dce5c","article-title":"Safety and immunogenicity of a novel quadrivalent meningococcal CRM-conjugate vaccine given concomitantly with routine vaccinations in infants","volume":"31","author":"Klein","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.tmaid.2014.04.011_bib12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/INF.0b013e31818e037d","article-title":"Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants","volume":"28","author":"Perrett","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.tmaid.2014.04.011_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.2007.29-c","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.tmaid.2014.04.011_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tmaid.2009.05.003","article-title":"Meningococcal disease and prevention at the Hajj","volume":"7","author":"Borrow","year":"2009","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.tmaid.2014.04.011_bib15","unstructured":"Ministry of Hajj. Umrah Visas. www.hajinformation.com\/main\/t1505.htm [accessed 11.02.14]."},{"key":"10.1016\/j.tmaid.2014.04.011_bib16","unstructured":"Cohn A, MacNeil JR. Meningococcal disease. In: centers for disease control and prevention. Yellow book. Chapter 3. http:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2014\/chapter-3-infectious-diseases-related-to-travel\/meningococcal-disease [accessed 11.02.14]."},{"key":"10.1016\/j.tmaid.2014.04.011_bib17","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1586\/erv.09.102","article-title":"Meningococcal vaccines: a neglected topic in travel medicine?","volume":"8","author":"Wilder-Smith","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"10","key":"10.1016\/j.tmaid.2014.04.011_bib18","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull World Health Organ"},{"issue":"8","key":"10.1016\/j.tmaid.2014.04.011_bib19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1586\/14760584.2013.835638","article-title":"IXIARO\u00ae updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis","volume":"12","author":"Jelinek","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tmaid.2014.04.011_bib20","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","article-title":"Safety and immunogenicity of a vero-cell-derived inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial","volume":"370","author":"Tauber","year":"2007","journal-title":"Lancet"},{"issue":"RR-1","key":"10.1016\/j.tmaid.2014.04.011_bib21","first-page":"1","article-title":"Centers for disease C, prevention. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Fischer","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.tmaid.2014.04.011_bib22","unstructured":"Hills SL, Weber IB, Fischer M. Japanese encephalitis. In: Centers for disease control and prevention. Yellow book. Chapter 3. http:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2014\/chapter-3-infectious-diseases-related-to-travel\/japanese-encephalitis [accessed 11.02.14]."},{"key":"10.1016\/j.tmaid.2014.04.011_bib23","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.tmaid.2014.04.011_bib24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.vaccine.2011.11.007","article-title":"Rabies vaccination for international travelers","volume":"30","author":"Gautret","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2014.04.011_bib25","unstructured":"WHO. Rabies vaccines. WHO Position Paper. WER 2010; 85:309\u201320."},{"key":"10.1016\/j.tmaid.2014.04.011_bib26","series-title":"Expert consultation on rabies","author":"WHO","year":"2013"},{"key":"10.1016\/j.tmaid.2014.04.011_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1708-8305.2011.00557.x","article-title":"Imported human rabies cases in europe, the United States, and Japan, 1990 to 2010","volume":"18","author":"Malerczyk","year":"2011","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2014.04.011_bib28","unstructured":"Rupprecht CE, Shlim DR. Rabies. In: Centers for disease control and prevention. Yellow book. Chapter 3. http:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2014\/chapter-3-infectious-diseases-related-to-travel\/rabies [accessed 11.02.14]."},{"issue":"2","key":"10.1016\/j.tmaid.2014.04.011_bib29","first-page":"1","article-title":"General recommendations on immunization \u2013 recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Kroger","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8391","key":"10.1016\/j.tmaid.2014.04.011_bib30","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(84)91893-2","article-title":"Chloroquine prophylaxis associated with a poor antibody response to human diploid cell Rabies vaccine","volume":"1","author":"Taylor","year":"1984","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.tmaid.2014.04.011_bib31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1056\/NEJM198601303140504","article-title":"Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine","volume":"314","author":"Pappaioanou","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2014.04.011_bib32","unstructured":"Menveo. Summary of product characteristics. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/001095\/WC500090147.pdf [accessed 13.09.13]."},{"key":"10.1016\/j.tmaid.2014.04.011_bib33","unstructured":"IXIARO. Summary of product characteristics. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000963\/WC500037287.pdf [accessed 13.09.13]."},{"key":"10.1016\/j.tmaid.2014.04.011_bib34","unstructured":"Rabipur. Summary of product characteristics. http:\/\/www.eda.mohp.gov.eg\/Download\/Docs\/Files\/36_SPC.pdf [accessed 13.09.13]."},{"issue":"6","key":"10.1016\/j.tmaid.2014.04.011_bib35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00063030-199809060-00002","article-title":"Clinically relevant vaccine-vaccine interactions: a guide for practitioners","volume":"9","author":"Gizurarson","year":"1998","journal-title":"BioDrugs"},{"issue":"37","key":"10.1016\/j.tmaid.2014.04.011_bib36","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1016\/j.vaccine.2011.05.019","article-title":"Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella","volume":"29","author":"Nascimento Silva","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2014.04.011_bib37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0264-410X(97)00207-7","article-title":"Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine","volume":"15","author":"Vodopija","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2014.04.011_bib38","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0264-410X(00)00342-X","article-title":"Purified chick embryo cell culture rabies vaccine: interchangeability with human diploid cell culture rabies vaccine and comparison of one versus two-dose post-exposure booster regimen for previously immunized persons","volume":"19","author":"Briggs","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2014.04.011_bib39","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0264-410X(96)00314-3","article-title":"A global review of rabies vaccines for human use","author":"Dreesen","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2014.04.011_bib40","unstructured":"Valneva Austria GmbH. Comparison of three Commercial Batches of the Japanese encephalitis vaccine IC51. Double blind, randomized, controlled phase 3 study. ClinicalTrials.gov Identifier NCT00595465. Results published online at: http:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00595465?term=IC51&rank=12&sect=X6015#outcome1 [accessed 24.10.13]."},{"issue":"33","key":"10.1016\/j.tmaid.2014.04.011_bib41","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1016\/j.vaccine.2009.05.034","article-title":"Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: a single-blind, randomized, controlled Phase 3 study","volume":"27","author":"Kaltenboeck","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.tmaid.2014.04.011_bib42","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/INF.0b013e3181906351","article-title":"A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine","volume":"28","author":"Pengsaa","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"26","key":"10.1016\/j.tmaid.2014.04.011_bib43","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1016\/j.vaccine.2012.03.080","article-title":"Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers","volume":"30","author":"Klein","year":"2012","journal-title":"Vaccine"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893914000854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893914000854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:59:46Z","timestamp":1761487186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893914000854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1477893914000854"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2014.04.011","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: A randomized, open-label, multi-center study","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2014.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}